Skip to main content
SpringerLink
Log in

Unstable angina: optimal therapy can prevent costly interventions

  • New Drugs and Therapeutic
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Which drug for stable angina? Drug Ther Perspect 1996; 8 (6): 5–8

  2. Brunelli C, Spallarossa P, Rossettin P, et al. Recognition and treatment of unstable angina. Drugs 1996; 52(2): 196–208

    Article  PubMed  CAS  Google Scholar 

  3. Conti CR. Pathophysiology and management of unstable angina [editorial]. Clin Cardiol 1989; 12(11): 616–7

    Article  PubMed  CAS  Google Scholar 

  4. Braunwald E. Unstable angina. A classification. Circulation 1989; 80(2): 410–4

    CAS  Google Scholar 

  5. Rizik DG, Healy S, Margulis A, et al. A new clinical classification for hopsital prognosis of unstable angina pectoris. Am J Cardiol 1995; 75(15): 993–7

    Article  PubMed  CAS  Google Scholar 

  6. Braunwald E, Mark DB, Jones RH, et al. Unstable angina: diagnosis and management. Clinical Practice Guideline no. 10. ACHPR publication No. 94–0602. Rockville (MD): Agency for Health Care Policy and Research and the National Heart, Lung, and Blood Institute, Public Health Service, US Department of Health and Human Services, 1994 May

  7. Bankwala Z, Swenson LJ. Unstable angina pectoris. What is the likelihood of further cardiac events? Postgrad Med 1995; 98(6): 155–65

    CAS  Google Scholar 

  8. Katz DA, Griffith JL, Beshansky JR, et al. The use of empiric clinical data in the evaluation of practice guidelines for unstable angina. JAMA 276: 1568–74

  9. Grambow DW, Topol EJ. Effect of maximal medical therapy on refractoriness of unstable angina pectoris. Am J Cardiol 1992; 70(6): 577–81

    Article  PubMed  CAS  Google Scholar 

  10. Antiplatelet Trialists’ Collaboration. Collaborative overview of randomized trial of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308(6921): 81–106

    Article  Google Scholar 

  11. Saltiel E, Ward A. Ticlopidine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in platelet-dependent disease states. Drugs 1987; 34(2): 22–6

    Article  Google Scholar 

  12. Gurfinkel EP, Manos EJ, Mejaìl RI, et al. Low moleular weight heparin versus regular heparin or aspirin in treatment of unstable angina and silent ischemia. J Am Coll Cardiol 1995; 26(2): 313–8

    Article  PubMed  CAS  Google Scholar 

  13. Fragmin During Instability in Coronary Artery Disease (FRISC) Study Group. Low molecular weight heparin during instability in coronary artery disease. Lancet 1996; 347: 561–8

    Google Scholar 

  14. The RISC Group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 1990; 336(8719): 827–30

    Article  Google Scholar 

  15. Theroux P, Ouimet H, McCans J, et al. Aspirin, heparin or both to treat unstable angina. N Engl J Med 1988; 319(17): 1105–11

    Article  PubMed  CAS  Google Scholar 

  16. Holdright D, Patel D, Cunningham D, et al. Comparison of the effect of heparin and aspirin alone on transient myocardial ischaemia and in-hospital prognosis in patients with unstable angina. J Am Coll Cardiol 1994; 24: 39–45

    Article  PubMed  CAS  Google Scholar 

  17. Cohen M, Adams PC, Parry G, et al. Combination antithrombotic therapy in unstable rest angina and non—Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Circulation 1994; 89(1): 89–8

    Google Scholar 

  18. Figueras J, Lidon R, Cortadellas J. Rebound myocardial ischaemia following abrupt interruption of intravenous nitroglycerin infusion in patients with unstable angina at rest. Eur Heart J 1991; 12(3): 405–11

    PubMed  CAS  Google Scholar 

  19. Abrams J. The role of nitrates in coronary heart disease. Arch Intern Med 1995; 155(4): 357–64

    Article  PubMed  CAS  Google Scholar 

  20. Lubsen J, Tijssen JG. Efficacy of nifedipine and metoprolol in the early treatment of unstable angina in the coronary care unit: findings from the Holland Interuniversity Nifedipine/metoprolol Trail (HINT). Am J Cardiol 1987; 60(2): 18A-25A

    Article  Google Scholar 

  21. Romeo F, Rosano GMC, Martuscelli E, et al. Effectiveness of prolonged low dose recombinant tissue-type plasminogen activator for refractory unstable angina. J Am Coll Cardiol 1995; 25(6): 1295–9

    Article  PubMed  CAS  Google Scholar 

  22. Schoebel FC, Leschke M, Stein D, et al. Chronic-intermittent urokinase therapy in refractory angina pectoris. Fibrinolysis 1995; 9 Suppl. 1: 121–5

    Google Scholar 

  23. Simoons ML, de Boer MJ, van den Brand MJ, et al. Randomized trial of a GPIIB/IIIA platelet receptor blocker in refractory unstable angina. Circulation 1994; 89(2): 596–603

    Article  PubMed  CAS  Google Scholar 

  24. COR’s integrelin better than aspirin? Scrip 1996 Nov 15; (2181): 22

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Unstable angina: optimal therapy can prevent costly interventions. Drugs Ther. Perspect 9, 8–11 (1997). https://doi.org/10.2165/00042310-199709040-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199709040-00003

Search

Navigation